$1.35 Million Grant to Better Predict Flu Outbreaks
News Jul 02, 2015
The researchers will look at changes to the flu virus’ envelope – the shell that lets it bind to and infect cells – as the virus adapts to different hosts. By better understanding this, scientists will be better able to determine the risk that a new virus could infect humans and potentially cause a pandemic.
“Previous research has mostly focused on changes in cell attachment and genome replication that are different between avian and human flu viruses, but our working hypothesis is that bird flu is subject to vastly different temperature and environment cycles upon transmission through the fecal-oral route than human flu, which is transmitted through aerosols and lung tissue,” said Tamm, of U.Va.’s Department of Molecular Physiology and Biological Physics. “Our international team of investigators will test the temperature hypothesis of host adaptation by looking at viral envelope remodeling as bird flu strains adapt to human transmission conditions.”
In bird flu’s current form, humans can contract it only through direct contact with birds. In the wake of increasing human infections, however, some scientists fear that a virus could mutate and become transmissible from person to person, possibly resulting in a pandemic akin to the Spanish flu that killed more than 50 million people in the early 20th century.
To better understand how the virus adapts to new hosts, Tamm will bring his expertise in membranes to a team that includes structural biologist Kay Grünewald of the University of Oxford in the United Kingdom; virologist Michael Veit of Freie Universität Berlin in Germany; and biochemist Markus Wenk of the National University of Singapore.
Tamm’s team will receive $450,000 each year for three years. It earned one of only 21 awards made from more than 900 applications. In evaluating Tamm’s grant application, one reviewer commented, “The comprehensive and interdisciplinary approach here … is innovative and highly professional.”
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.